BG61607B1 - Пуринови производни - Google Patents

Пуринови производни Download PDF

Info

Publication number
BG61607B1
BG61607B1 BG99741A BG9974195A BG61607B1 BG 61607 B1 BG61607 B1 BG 61607B1 BG 99741 A BG99741 A BG 99741A BG 9974195 A BG9974195 A BG 9974195A BG 61607 B1 BG61607 B1 BG 61607B1
Authority
BG
Bulgaria
Prior art keywords
thio
formula
compound
benzothiazolyl
propyl
Prior art date
Application number
BG99741A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99741A (bg
Inventor
Jesper Lau
Lars J. Knutsen
Malcolm Sheardown
Anker J. Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BG99741A publication Critical patent/BG99741A/bg
Publication of BG61607B1 publication Critical patent/BG61607B1/bg

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG99741A 1992-12-23 1995-06-22 Пуринови производни BG61607B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK921552A DK155292D0 (da) 1992-12-23 1992-12-23 Kemiske forbindelser, deres fremstilling og anvendelse
PCT/DK1993/000434 WO1994014832A1 (en) 1992-12-23 1993-12-21 Purine derivatives

Publications (2)

Publication Number Publication Date
BG99741A BG99741A (bg) 1996-04-30
BG61607B1 true BG61607B1 (bg) 1998-01-30

Family

ID=8105999

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99741A BG61607B1 (bg) 1992-12-23 1995-06-22 Пуринови производни

Country Status (18)

Country Link
US (1) US5484774A (da)
EP (1) EP0675896A1 (da)
JP (1) JPH08504777A (da)
KR (1) KR960700260A (da)
AU (1) AU690532B2 (da)
BG (1) BG61607B1 (da)
CA (1) CA2152341A1 (da)
CZ (1) CZ164295A3 (da)
DK (1) DK155292D0 (da)
FI (1) FI953127A7 (da)
HU (1) HUT72409A (da)
IL (1) IL108119A0 (da)
NO (1) NO952508L (da)
NZ (1) NZ259323A (da)
PL (1) PL175029B1 (da)
SK (1) SK82695A3 (da)
WO (1) WO1994014832A1 (da)
ZA (1) ZA939663B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683989A (en) * 1993-12-17 1997-11-04 Novo Nordisk A/S Treatment of ischemias by administration of 2,N6 -substituted adenosines
AU2603197A (en) 1996-04-10 1997-10-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
GB9610031D0 (en) * 1996-05-14 1996-07-17 Glaxo Group Ltd Chemical compounds
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
GB9913932D0 (en) 1999-06-15 1999-08-18 Pfizer Ltd Purine derivatives
JP2001163854A (ja) * 1999-09-28 2001-06-19 Nippon Nohyaku Co Ltd チオアルキルアミン誘導体及びその製造方法
US7342003B2 (en) * 2001-10-25 2008-03-11 King Pharmaceuticals Research And Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
US20110087015A1 (en) * 2003-09-10 2011-04-14 Riken Nucleoside and nucleotide having an unnatural base and use thereof
WO2005033121A2 (en) * 2003-10-03 2005-04-14 King Pharmaceuticals Research & Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
CN101041638B (zh) * 2007-04-29 2010-05-26 浙江工业大学 含咪唑硫醚结构的手性胺及其制备方法与应用
CN101041637B (zh) * 2007-04-29 2010-06-09 浙江工业大学 含咪唑硫醚结构的手性胺质子酸盐及其制备方法与应用
CN105273027B (zh) * 2014-07-22 2018-11-06 上海医药工业研究院 坎格雷洛中间体及其制备方法和应用
CN105273025B (zh) * 2014-07-22 2019-07-26 上海医药工业研究院 一种制备坎格雷洛的中间体及其制备方法和应用
CN105273026B (zh) * 2014-07-22 2018-11-06 上海医药工业研究院 一种药物中间体及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
EP0300144A3 (en) * 1984-04-18 1989-09-27 Whitby Research Incorporated N-6 alkyl substituted adenosine derivatives as cardiac vasodilators
IE903747A1 (en) * 1989-10-19 1991-04-24 Searle & Co Method of treating gastrointestinal motility disorders
US5055569A (en) * 1989-10-19 1991-10-08 G. D. Searle & Co. N-(6)-substituted adenosine compounds
AU654507B2 (en) * 1990-09-25 1994-11-10 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
DK62692D0 (da) * 1992-05-14 1992-05-14 Novo Nordisk As
WO1994002497A1 (en) * 1992-07-15 1994-02-03 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Sulfo-derivatives of adenosine

Also Published As

Publication number Publication date
NZ259323A (en) 1996-06-25
KR960700260A (ko) 1996-01-19
NO952508D0 (no) 1995-06-22
IL108119A0 (en) 1994-04-12
HU9501856D0 (en) 1995-08-28
DK155292D0 (da) 1992-12-23
BG99741A (bg) 1996-04-30
ZA939663B (en) 1995-06-23
SK82695A3 (en) 1996-04-03
EP0675896A1 (en) 1995-10-11
CZ164295A3 (en) 1996-01-17
PL175029B1 (pl) 1998-10-30
WO1994014832A1 (en) 1994-07-07
AU690532B2 (en) 1998-04-30
FI953127L (fi) 1995-08-21
FI953127A7 (fi) 1995-08-21
PL309610A1 (en) 1995-10-30
JPH08504777A (ja) 1996-05-21
NO952508L (no) 1995-08-22
US5484774A (en) 1996-01-16
HUT72409A (en) 1996-04-29
FI953127A0 (fi) 1995-06-22
AU5809394A (en) 1994-07-19
CA2152341A1 (en) 1994-07-07

Similar Documents

Publication Publication Date Title
AU678053B2 (en) Chemical compounds, their preparation and use
US5578582A (en) Methods of treating ischemia with C2, N6 -disubstituted adenosine derivatives
ES2324816T3 (es) Derivados de 2-aminocarbonil-9h-purina.
BG61607B1 (bg) Пуринови производни
US20100331397A1 (en) 2-5a analogs and their methods of use
CA2400619A1 (en) Purine derivatives
CZ273193A3 (en) N4-alkoxycarbonyl -5°-deoxy-5-fluorocytidine derivatives, pharmaceutical preparations in which they are comprised and process for preparing thereof
SK91895A3 (en) 2,6-diaminopurine derivatives, method of their preparation, their use for production of farmaceutical agents and farmaceutical agents containing them
CN109906083B (zh) 含有腺苷衍生物的药物组合物
JP6671355B2 (ja) 呼吸器多核体ウイルスのrna複製の阻害剤としての4’‐ビニル置換ヌクレオシド誘導体
KR20030089512A (ko) C2,5'-이치환된 및 n6,c2,5'-삼치환된 아데노신 유도체및 그들의 상이한 용도
EP0607367A1 (en) Novel adenosine derivatives
US5683989A (en) Treatment of ischemias by administration of 2,N6 -substituted adenosines
JP2022531899A (ja) Stingモジュレータとしての修飾環状ジヌクレオシド化合物
WO1998016539A1 (en) Novel therapeutically active adenosine derivatives
Kisakürek Perspectives in nucleoside and nucleic acid chemistry